# D. Staumont‐Sallé

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/d-staumont-salle/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,233 |
| Field | Dermatology and Skin Diseases |
| h-index | 31 |
| i10-index | 64 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5043652725 |
| ORCID iD | 0000-0002-4780-4212 |
| Works | 348 |

## Researcher papers

- [Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis](https://scholariq.org/papers/effect-of-dupilumab-on-blood-eosinophil-counts-in-patients-with-asthma-chronic/)
- [Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort](https://scholariq.org/papers/effectiveness-and-safety-of-dupilumab-for-the-treatment-of-atopic-dermatitis-in/)
- [Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR](https://scholariq.org/papers/metabolic-and-innate-immune-cues-merge-into-a-specific-inflammatory-response-via/)
- [The Lymphoid Variant of Hypereosinophilic Syndrome](https://scholariq.org/papers/the-lymphoid-variant-of-hypereosinophilic-syndrome/)
- [Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial](https://scholariq.org/papers/methotrexate-versus-cyclosporine-in-adults-with-moderate-to-severe-atopic/)
- [CD3<sup>bright</sup> signals on γδ T cells identify IL‐17A‐producing Vγ6Vδ1<sup>+</sup> T cells](https://scholariq.org/papers/cd3-sup-bright-sup-signals-on-t-cells-identify-il-17a-producing-v-6v-1-sup-sup-t/)
- [Peroxisome proliferator-activated receptor α regulates skin inflammation and humoral response in atopic dermatitis](https://scholariq.org/papers/peroxisome-proliferator-activated-receptor-regulates-skin-inflammation-and/)
- [Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab](https://scholariq.org/papers/development-or-exacerbation-of-head-and-neck-dermatitis-in-patients-treated-for/)
- [Eosinophil-derived IFN-γ induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes](https://scholariq.org/papers/eosinophil-derived-ifn-induces-airway-hyperresponsiveness-and-lung-inflammation/)
- [Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials](https://scholariq.org/papers/safety-of-tralokinumab-in-adult-patients-with-moderate-to-severe-atopic/)
- [The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support](https://scholariq.org/papers/the-atopic-dermatitis-control-tool-a-high-performance-tool-for-optimal-support/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Drug-Induced Adverse Reactions](https://scholariq.org/topics/drug-induced-adverse-reactions/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.